je.st
news
Janssen announces acquisition of XO1
2015-03-19 17:25:24| Biotech - Topix.net
Janssen Pharmaceuticals, Inc. , one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab. Financial terms of the transaction have not been disclosed.
Tags: acquisition
announces
janssen
announces acquisition
Category:Biotechnology and Pharmaceuticals